Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer

Figure 3

Verification of the efficiency of the prognostic prediction model in patients with ovarian cancer. (a) RIPK4 expression is associated with overall survival in patients with ovarian tumor. (b) The overall survival rate in the high- and low-risk groups according to the prognostic prediction model. (c) The time-dependent receiver operating characteristic curves at different years. (d) A heat map representing the age, stage, and RIPK4 expression for every patient with ovarian tumor based on The Cancer Genome Atlas data.

(a)

(b)

(c)

(d)